The Reporting Persons have the shared power to vote or direct the vote, and the shared power to dispose or to direct the disposition of all 3,737,747 shares of Class A Common Stock described in the cover page of this Schedule 13D.
(c) Except as disclosed in Item 6 of this Schedule 13D (which is incorporated herein by reference), and as reported on the Forms 4 jointly filed by the Reporting Persons with the SEC on March 8, 2023 and March 10, 2023, none of the Reporting Persons effected any transaction in securities of the Issuer in the past 60 days.
(d) No person, other than the Reporting Persons, is known to have the right to receive or the power to direct the receipt of dividends from, or any proceeds from the sale of, the shares of Class A Common Stock beneficially owned by the Reporting Persons.
(e) Inapplicable.
Item 6. | Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer |
This Amendment adds the text set forth below immediately after the final paragraph under the subheading “Follow-on Offering” in Item 6 of the Original Schedule 13D:
2023 Offering
On March 7, 2023, Holdco I and Holdco II, as selling stockholders, entered into an Underwriting Agreement (the “Underwriting Agreement”), by and among the Issuer, Parent, Holdco I, Holdco II, and Morgan Stanley & Co. LLC (the “Underwriter”), relating to the public offering of an aggregate 24,501,650 shares of Class A Common Stock by Holdco I and Holdco II (collectively, the “2023 Offering”). The Underwriting Agreement contains customary representations, warranties, covenants and indemnification obligations of Holdco I and Holdco II, as well as other customary provisions. Pursuant to the Underwriting Agreement, Holdco I and Holdco II granted the Underwriters an overallotment option (the “Overallotment Option”) to purchase up to an additional 3,675,247 shares of Class A Common Stock.
The 2023 Offering was made pursuant to the Issuer’s automatic shelf registration statement on Form S-3 (File No. 333-268610) that became effective under the Securities Act of 1933, as amended, when filed with the SEC on November 30, 2022, and a related prospectus supplement dated March 7, 2023, and filed with the SEC on March 9, 2023. The 2023 Offering closed on March 10, 2023.
In connection with the 2023 Offering, Holdco I, Holdco II and Founder entered into lock-up agreements, copies of which are filed as Exhibits 4, 5, and 6 to this Schedule 13D (the “2023 Lock-Up Agreements”), respectively, with the Underwriters pursuant to which Holdco I, Holdco II, and Founder, subject to certain exceptions, for a period of 90 days after the date of the Final Prospectus, may not, without the prior written consent of the Underwriter, (i) offer, sell, contract to sell, pledge, grant any option to purchase, lend or otherwise dispose of any shares of Common Stock, or any common units of Parent, or any options or warrants to purchase any shares of Common Stock or common units of Parent, or any securities convertible into, exchangeable for or that represent the right to receive shares of Common Stock or any common units of Parent (such options, warrants or other securities, collectively, “Derivative Instruments”), including without limitation any such shares, units or Derivative Instruments now owned or hereafter acquired by Holdco I, Holdco II, or Founder (collectively, the “2023 Lock-Up Securities”), (ii) engage in any hedging or other transaction or arrangement (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) which is designed to or which reasonably could be expected to lead to or result in a sale, loan, pledge or other disposition (whether by the undersigned or someone other than the undersigned), or transfer of any of the economic consequences of ownership, in whole or in part, directly or indirectly, of the 2023 Lock-Up Securities, whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery of Common Stock or other securities, in cash or otherwise (any such sale, loan, pledge or
other disposition, or transfer of economic consequences, or (iii) otherwise publicly announce any intention to engage in or cause any action or activity described in clause (i) above or transaction or arrangement described in clause (ii) above.
The description of the 2023 Lock-Up Agreements in this Item 6 of this Schedule 13D is a summary only and is qualified in its entirety by the actual terms of the 2023 Lock-Up Agreements, copies of which are filed as Exhibits 4, 5, and 6 to this Schedule 13D.